Novus Int. signs agreement with Chr. Hansen
Novus International, Inc. and Chr. Hansen, Inc., signed an agreement last week at World Pork Expo (WPX). This agreement combines the strengths of both organizations with respect to sales and technical competencies to position BioPlus 2B® (BP) to the swine industry in the United States.
BP a direct fed microbial (DFM), contains two strains of Bacillus (Bacillus licheniformis and Bacillus subtilis). These Bacillus strains can improve the intestinal microbial balance of swine. Safety studies have proven that BP strains are totally safe to animals and humans. The data was compiled into more than 5,000 pages to get final approval in the European Union for all swine categories.
“This partnership compliments our GEMS nutrition program and gut health management portfolio,” stated Dan Meagher, Vice President, Americas. “Novus International is focused on providing producers, nutritionists and veterinarians with ways to optimize pig health and performance.”
“The cooperation with Novus International immediately broadens our access to the swine market in the United States. We expect strong growth in sales with this cooperation”, explains Dr. Bill Braman, VP Marketing and Sales Animal Health & Nutrition, Chr. Hansen NA.
Related websites:
Novus International
Chr. Hansen
Related folder:
Dossier AllAbout Probiotics
Join 26,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the feed sector, three times a week.
